Novel Actinium and Radium Nanoconstructs Show Promise for Targeted Cancer Radiotherapy

Targeted alpha-particle therapy is an emerging approach to treating cancer that aims to deliver radiation precisely to tumours while sparing healthy tissue. Dr Sandra Davern from Oak Ridge National Laboratory and her colleagues are at the forefront of developing new lanthanide vanadate nanoconstructs doped with alpha-emitting radionuclides for this application. Their recent work provides key insights into the structure and properties of these novel nanomaterials, paving the way for more effective radiotherapies.